Coaching chronic disease with AI-powered clinical intelligence - Welldoc

Our latest episode features Anand Iyer, Chief AI Officer at Welldoc, whose journey from building the first telematics model for GM's OnStar system to transforming chronic disease management demonstrates how AI can bridge the gap between doctor visits and daily patient decisions.

After his own diabetes diagnosis, Anand redirected his wireless technology and AI expertise toward a critical challenge: the 99% of time patients spend managing chronic conditions without their doctors. At Welldoc, he's built BlueStar, a Class II FDA-regulated medical device that has evolved into a comprehensive cardio-metabolic platform managing diabetes, hypertension, heart failure, weight management, and mental health within a single app.

Anand walks us through Welldoc's AI evolution: from rules-based logic required for early FDA acceptance to machine learning and now Generative AI trained on clinical guidelines in private data environments. Central to their philosophy is the "learned intermediary" model: the AI doesn't practice medicine autonomously but empowers patients with real-time feedback and equips doctors to overcome clinical inertia.

Welldoc has transformed from a prescription-only product to an FDA-cleared over-the-counter SaaS platform serving health plans, employers, and hospital systems.

This episode is a must-listen for anyone interested in AI-driven chronic disease management, FDA-regulated digital therapeutics, or building scalable clinical decision support platforms that truly change patient outcomes.